About Oculis Holding AG 
Oculis Holding AG
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 7 Schemes (4.13%)
Foreign Institutions
Held by 18 Foreign Institutions (16.64%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
(Quarterly Results - Dec 2025)
Net Profit:
-29 Million
Pharmaceuticals & Biotechnology
USD 1,579 Million (Small Cap)
NA (Loss Making)
NA
0.00%
-1.11
-58.75%
9.62






